|
|
|
|
LEADER |
02226 am a22002533u 4500 |
001 |
36928 |
042 |
|
|
|a dc
|
100 |
1 |
0 |
|a Muhammad Salman, Muhammad Salman
|e author
|
700 |
1 |
0 |
|a Khan, Amer Hayat
|e author
|
700 |
1 |
0 |
|a Adnan, Azreen Syazril
|e author
|
700 |
1 |
0 |
|a Syed Sulaiman, Syed Azhar
|e author
|
700 |
1 |
0 |
|a Shehzadi, Naureen
|e author
|
700 |
1 |
0 |
|a Asif, Nauman
|e author
|
700 |
1 |
0 |
|a Hussain, Khalid
|e author
|
700 |
1 |
0 |
|a Saleem, Fahad
|e author
|
700 |
1 |
0 |
|a Raza, Muhammed Hussnain
|e author
|
700 |
1 |
0 |
|a Farooq, Muhammad Shahid
|e author
|
245 |
0 |
0 |
|a Evaluation of Medication Use in Malaysian Predialysis Patients
|
260 |
|
|
|b Medknow Publications,
|c 2017.
|
856 |
|
|
|z Get fulltext
|u http://eprints.usm.my/36928/1/%28Evaluation_of_medication_use%29_SaudiJKidneyDisTranspl283517-7557673_205936.pdf
|
520 |
|
|
|a Chronic kidney disease (CKD) patients suffer from multiple comorbidities and complications as a cause or consequence of kidney disease. Information regarding medicationprescribing patterns in predialysis patients is sparse. We conducted a retrospective study to evaluate the medication prescription patterns among predialysis patients. Medical records (both paper based and computerized) of patients at CKD Resource Centre, Hospital Universiti Sains Malaysia, were reviewed. A total of 615 eligible cases were included in the study. The mean number of medications prescribed per patient was 8.22 ± 2.81, and medication use was correlated to the renal function (stage 3a < stage 3b < stage 4 < stage 5; P <0.001). The top three prescribed medication groups were found to be lipid-lowering agents, calcium channel blockers, and antiplatelet agents. Some medication classes such as nonaluminum/noncalcium phosphate binders, erythropoietin-stimulating agents, and renin-angiotensin-aldosterone system blockers, particularly in advanced stage, were found to be underutilized. In conclusion, predialysis patients are prescribed a large number of medications. Our findings highlight the need for assessing the impact of current medication-prescribing patterns on morbidity and mortality rates in Malaysian predialysis population.
|
546 |
|
|
|a en
|
650 |
0 |
4 |
|a R Medicine (General)
|
650 |
0 |
4 |
|a RS Pharmacy and materia medica
|